Holen Sie sich die Stockscreener-App
26.45
2.01%
-0.52
Schlusskurs vom Vortag:
$26.97
Offen:
$26.75
24-Stunden-Volumen:
603.24K
Relative Volume:
0.18
Marktkapitalisierung:
$4.89B
Einnahmen:
$637.78M
Nettoeinkommen (Verlust:
$239.40M
KGV:
22.21
EPS:
1.1909
Netto-Cashflow:
$307.21M
1W Leistung:
+8.31%
1M Leistung:
-25.03%
6M Leistung:
-61.43%
1J Leistung:
-61.04%
1-Tages-Spanne:
$25.96
$26.92
1-Wochen-Bereich:
$23.84
$27.06
52-Wochen-Spanne:
$23.53
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
26.45 | 4.98B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
185.65 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.14 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.62 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.38 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.42 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Doximity Analysts Set $44.50 Average Price Target - National Today
DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan
Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - TradingView
Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - simplywall.st
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - Finviz
Intech Investment Management Trims Doximity Holdings - National Today
Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services - DirectorsTalk Interviews
Intech Investment Management LLC Has $3.57 Million Holdings in Doximity, Inc. $DOCS - MarketBeat
William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS - MarketBeat
Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Handelsbanken Fonder AB Acquires 180,700 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity CEO ViVE 2026 Talk Puts AI And Pharma Story In Focus - Sahm
Doximity, Inc. Hits New 52-Week Low at $23.57 Amid Market Decline - Markets Mojo
Doximity Investors' $31M Deal Over User Slowdown OK'd - Law360
ZoomInfo, SentinelOne, Toast, Doximity, and American Express Global Business Travel Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity’s $31 Million Investor Settlement Clears Initial Hurdle - Bloomberg Law News
Doximity Stock Hits Day Low of $23.58 Amid Price Pressure - Markets Mojo
Doximity, Inc. Stock Plummets to New 52-Week Low of $23.58 - Markets Mojo
Doximity Stock Analysts Adjust Ratings and Targets - National Today
Doximity Expands AI Tools As Investors Weigh Profit Strength And Growth - Sahm
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Doximity (DOCS) Price Target Decreased by 31.04% to 44.25 - Nasdaq
(DOCS) Risk Channels and Responsive Allocation - Stock Traders Daily
Doximity stock hits 52-week low at $23.65 amid challenging year - Investing.com Australia
Doximity (NASDAQ:DOCS) Sets New 12-Month Low on Analyst Downgrade - MarketBeat
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight. - The Motley Fool
Piper Sandler raises Doximity stock price target on AI tools By Investing.com - Investing.com Australia
Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at JPMorgan Chase & Co. - MarketBeat
Piper Sandler raises Doximity stock price target on AI tools - Investing.com
Piper Sandler Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat
Piper Sandler Raises Price Target for Doximity (DOCS) to $42 | D - GuruFocus
Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year - TIKR.com
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Why Doximity Stock Plummeted Today - AOL.com
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Insider Monkey
Canaccord Calls Doximity, Inc. (DOCS)'s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Bitget
Doximity Inc. (NYSE:DOCS) Fits the "Affordable Growth" Investment Strategy - ChartMill
Doximity, Inc. (DOCS) Stock Analysis: Exploring a 60% Upside Potential in the Healthcare Information Sector - DirectorsTalk Interviews
How Doximity Inc. stock trades before earnings2025 AllTime Highs & Expert Verified Movement Alerts - mfd.ru
How Doximity Inc. stock performs in weak economyExit Point & Trade Opportunity Analysis - mfd.ru
Doximity (DOCS) Is Down 9.8% After Big Buybacks and Mixed Q3 Signals Has The Bull Case Changed? - Yahoo Finance
DOCS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
April 17th Options Now Available For Doximity (DOCS) - Nasdaq
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
Trend Recap: Is Doximity Inc stock suitable for long term investing2025 Market Trends & AI Driven Price Forecasts - baoquankhu1.vn
Doximity (DOCS) Is Down 9.8% After New AI Spend, Buyback Plan And Guidance Update – Has The Bull Case Changed? - Sahm
DOCS Stock Falls -30% With A 6-day Losing Spree On Weak Guidance - Trefis
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Doximity's (NYSE:DOCS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):